ID   ING1_HUMAN              Reviewed;         422 AA.
AC   Q9UK53; O00532; O43658; Q53ZR3; Q5T9G8; Q5T9G9; Q5T9H0; Q5T9H1; Q9H007;
AC   Q9HD98; Q9HD99; Q9NS83; Q9P0U6; Q9UBC6; Q9UIJ1; Q9UIJ2; Q9UIJ3; Q9UIJ4;
AC   Q9UK52;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   04-NOV-2008, sequence version 2.
DT   07-APR-2021, entry version 176.
DE   RecName: Full=Inhibitor of growth protein 1;
GN   Name=ING1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND VARIANT ARG-125.
RX   PubMed=8944021; DOI=10.1038/ng1296-415;
RA   Garkavtsev I.A., Kazarov A.R., Gudkov A.V., Riabowol K.;
RT   "Suppression of the novel growth inhibitor p33ING1 promotes neoplastic
RT   transformation.";
RL   Nat. Genet. 14:415-420(1996).
RN   [2]
RP   ERRATUM OF PUBMED:8944021.
RA   Garkavtsev I.A., Kazarov A.R., Gudkov A.V., Riabowol K.;
RL   Nat. Genet. 23:373-373(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 4), AND TISSUE SPECIFICITY.
RC   TISSUE=Mammary cancer, and Testis;
RX   PubMed=10626813;
RA   Jaeger D., Stockert E., Scanlan M.J., Guere A.O., Jaeger E., Knuth A.,
RA   Old L.J., Chen Y.-T.;
RT   "Cancer-testis antigens and ING1 tumor suppressor gene product are breast
RT   cancer antigens: characterization of tissue-specific ING1 transcripts and a
RT   homologue gene.";
RL   Cancer Res. 59:6197-6204(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ISOFORMS 1 AND 2).
RX   PubMed=10779953;
RA   Baranova A.V., Ivanov D.V., Makeeva N.V., Corcoran M., Nikitin E.A.,
RA   Borodina T.A., Poltaraus A.B., Glinshchikova O.A., Sudarikov A.B.,
RA   Oscier D., Iankovskii N.K.;
RT   "Genomic organization of the suppressor gene for tumor growth ING1.";
RL   Mol. Biol. (Mosk.) 34:263-269(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1; 2; 3 AND 5), AND VARIANTS
RP   HNSCC ARG-125; ASP-335; SER-358 AND SER-359.
RX   PubMed=10866301;
RA   Gunduz M., Ouchida M., Fukushima K., Hanafusa H., Etani T., Nishioka S.,
RA   Nishizaki K., Shimizu K.;
RT   "Genomic structure of the human ING1 gene and tumor-specific mutations
RT   detected in head and neck squamous cell carcinomas.";
RL   Cancer Res. 60:3143-3146(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1; 2 AND 3), AND VARIANT
RP   ARG-125.
RX   PubMed=10807544; DOI=10.1007/s100380050206;
RA   Saito A., Furukawa T., Fukushige S., Koyama S., Hoshi M., Hayashi Y.,
RA   Horii A.;
RT   "p24/ING1-ALT1 and p47/ING1-ALT2, distinct alternative transcripts of
RT   p33/ING1.";
RL   J. Hum. Genet. 45:177-181(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 2).
RC   TISSUE=Brain;
RA   Nouman G.S., Anderson J.J., Angus B., Lunec J.;
RT   "Supplement: sequencing of ING1 tumour suppressor gene cDNAs generated from
RT   mRNA recovered from normal and neoplastic cell lines.";
RL   J. Pathol. 192:266-266(2000).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2).
RX   PubMed=11481424; DOI=10.1073/pnas.161151798;
RA   Nagashima M., Shiseki M., Miura K., Hagiwara K., Linke S.P., Pedeux R.,
RA   Wang X.W., Yokota J., Riabowol K., Harris C.C.;
RT   "DNA damage-inducible gene p33ING2 negatively regulates cell proliferation
RT   through acetylation of p53.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:9671-9676(2001).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH TP53.
RX   PubMed=9440695; DOI=10.1038/34675;
RA   Garkavtsev I.A., Grigorian I.A., Ossovskaya V.S., Chernov M.V.,
RA   Chumakov P.M., Gudkov A.V.;
RT   "The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth
RT   control.";
RL   Nature 391:295-298(1998).
RN   [14]
RP   DOMAIN PHD-TYPE ZINC-FINGER, AND INTERACTION WITH HISTONES H3K4ME3 AND
RP   H3K4ME2.
RX   PubMed=16728974; DOI=10.1038/nature04835;
RA   Shi X., Hong T., Walter K.L., Ewalt M., Michishita E., Hung T., Carney D.,
RA   Pena P., Lan F., Kaadige M.R., Lacoste N., Cayrou C., Davrazou F., Saha A.,
RA   Cairns B.R., Ayer D.E., Kutateladze T.G., Shi Y., Cote J., Chua K.F.,
RA   Gozani O.;
RT   "ING2 PHD domain links histone H3 lysine 4 methylation to active gene
RT   repression.";
RL   Nature 442:96-99(2006).
RN   [15]
RP   INTERACTION WITH RSL1D1.
RX   PubMed=22419112; DOI=10.1038/cddis.2012.22;
RA   Li N., Zhao G., Chen T., Xue L., Ma L., Niu J., Tong T.;
RT   "Nucleolar protein CSIG is required for p33ING1 function in UV-induced
RT   apoptosis.";
RL   Cell Death Dis. 3:E283-E283(2012).
RN   [16]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-278, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 345-404 IN COMPLEX WITH H3K4ME3
RP   AND ZINC, AND MUTAGENESIS OF TRP-378.
RX   PubMed=18533182; DOI=10.1016/j.jmb.2008.04.061;
RA   Pena P.V., Hom R.A., Hung T., Lin H., Kuo A.J., Wong R.P., Subach O.M.,
RA   Champagne K.S., Zhao R., Verkhusha V.V., Li G., Gozani O.,
RA   Kutateladze T.G.;
RT   "Histone H3K4me3 binding is required for the DNA repair and apoptotic
RT   activities of ING1 tumor suppressor.";
RL   J. Mol. Biol. 380:303-312(2008).
CC   -!- FUNCTION: Cooperates with p53/TP53 in the negative regulatory pathway
CC       of cell growth by modulating p53-dependent transcriptional activation.
CC       Implicated as a tumor suppressor gene. {ECO:0000269|PubMed:9440695}.
CC   -!- SUBUNIT: Interacts with H3K4me3 and to a lesser extent with H3K4me2.
CC       Interacts with TP53. Isoform 2 interacts with RSL1D1.
CC       {ECO:0000269|PubMed:16728974, ECO:0000269|PubMed:18533182,
CC       ECO:0000269|PubMed:22419112, ECO:0000269|PubMed:9440695}.
CC   -!- INTERACTION:
CC       Q9UK53; P15559: NQO1; NbExp=3; IntAct=EBI-399198, EBI-3989435;
CC       Q9UK53-2; Q96A65-2: EXOC4; NbExp=3; IntAct=EBI-8068204, EBI-17869840;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=p47ING1a, ING1-ALT2;
CC         IsoId=Q9UK53-1; Sequence=Displayed;
CC       Name=2; Synonyms=p33ING1b, Variant A;
CC         IsoId=Q9UK53-2; Sequence=VSP_009126;
CC       Name=3; Synonyms=p24ING1c, ING1-ALT1, Variant B;
CC         IsoId=Q9UK53-3; Sequence=VSP_009129;
CC       Name=4; Synonyms=Variant C;
CC         IsoId=Q9UK53-4; Sequence=VSP_009127;
CC       Name=5;
CC         IsoId=Q9UK53-5; Sequence=VSP_009128;
CC   -!- TISSUE SPECIFICITY: Isoform 2 was expressed in all normal tissues and
CC       cells examined, as well as in all breast cancer and melanoma cell lines
CC       examined. Isoform 3 was expressed in testis, liver, and kidney, weakly
CC       expressed in colon and brain and not expressed in breast and cultured
CC       melanocytes. Isoform 4 was highly expressed in testis and weakly
CC       expressed in brain, but not expressed in breast, colon, kidney,
CC       melanocytes, breast cancer or melanoma cell lines.
CC       {ECO:0000269|PubMed:10626813}.
CC   -!- DOMAIN: The PHD-type zinc finger mediates the binding to H3K4me3.
CC       {ECO:0000269|PubMed:16728974}.
CC   -!- DOMAIN: The polybasic region (PBR) is responsive to the binding to
CC       phosphoinositides (PtdInsPs), including phosphatidylinositol 5-
CC       phosphate (PtdIns(5)P). {ECO:0000250|UniProtKB:Q9H160}.
CC   -!- DISEASE: Squamous cell carcinoma of the head and neck (HNSCC)
CC       [MIM:275355]: A non-melanoma skin cancer affecting the head and neck.
CC       The hallmark of cutaneous SCC is malignant transformation of normal
CC       epidermal keratinocytes. {ECO:0000269|PubMed:10866301}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the ING family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB60879.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAG02579.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF181849; AAF07920.1; -; mRNA.
DR   EMBL; AF181850; AAF07921.1; -; mRNA.
DR   EMBL; AF001954; AAB60879.1; ALT_FRAME; mRNA.
DR   EMBL; AF044076; AAC00501.1; -; mRNA.
DR   EMBL; AF149721; AAF37421.1; -; mRNA.
DR   EMBL; AF149722; AAF37422.1; -; mRNA.
DR   EMBL; AF149723; AAF37423.1; -; mRNA.
DR   EMBL; AF167551; AAG02578.1; -; Genomic_DNA.
DR   EMBL; AF167550; AAG02578.1; JOINED; Genomic_DNA.
DR   EMBL; AF167551; AAG02579.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AF167549; AAG02579.1; JOINED; Genomic_DNA.
DR   EMBL; AB037387; BAB08101.1; -; Genomic_DNA.
DR   EMBL; AB037387; BAB08102.1; -; Genomic_DNA.
DR   EMBL; AB037387; BAB08103.1; -; Genomic_DNA.
DR   EMBL; AB037594; BAB20992.2; -; mRNA.
DR   EMBL; AB031269; BAA83496.1; -; mRNA.
DR   EMBL; AB024401; BAA82886.1; -; mRNA.
DR   EMBL; AB024402; BAA82887.1; -; mRNA.
DR   EMBL; AB024403; BAA82888.1; -; Genomic_DNA.
DR   EMBL; AB024404; BAA82889.1; -; Genomic_DNA.
DR   EMBL; AB024404; BAA83462.1; -; Genomic_DNA.
DR   EMBL; AB024405; BAA82890.1; -; Genomic_DNA.
DR   EMBL; AJ310392; CAC38067.1; -; mRNA.
DR   EMBL; AF078835; AAG12174.1; -; mRNA.
DR   EMBL; AF078837; AAG12175.1; -; Genomic_DNA.
DR   EMBL; AF078836; AAG12175.1; JOINED; Genomic_DNA.
DR   EMBL; AK302353; BAG63679.1; -; mRNA.
DR   EMBL; AL157820; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471085; EAX09127.1; -; Genomic_DNA.
DR   EMBL; CH471085; EAX09130.1; -; Genomic_DNA.
DR   EMBL; BC093942; AAH93942.1; -; mRNA.
DR   EMBL; BC093944; AAH93944.1; -; mRNA.
DR   CCDS; CCDS9515.1; -. [Q9UK53-4]
DR   CCDS; CCDS9516.1; -. [Q9UK53-2]
DR   CCDS; CCDS9517.1; -. [Q9UK53-1]
DR   CCDS; CCDS9518.1; -. [Q9UK53-3]
DR   RefSeq; NP_001254657.1; NM_001267728.1. [Q9UK53-5]
DR   RefSeq; NP_005528.4; NM_005537.5.
DR   RefSeq; NP_937860.1; NM_198217.2. [Q9UK53-4]
DR   RefSeq; NP_937861.1; NM_198218.2. [Q9UK53-3]
DR   RefSeq; NP_937862.1; NM_198219.2. [Q9UK53-2]
DR   PDB; 2QIC; X-ray; 2.10 A; A=345-404.
DR   PDBsum; 2QIC; -.
DR   SMR; Q9UK53; -.
DR   BioGRID; 109833; 84.
DR   ComplexPortal; CPX-3321; SIN3A histone deacetylase complex.
DR   ComplexPortal; CPX-3322; SIN3B histone deacetylase complex.
DR   ComplexPortal; CPX-3323; SIN3A histone deacetylase complex, ES cell-specific variant.
DR   CORUM; Q9UK53; -.
DR   DIP; DIP-24256N; -.
DR   DIP; DIP-24257N; -.
DR   DIP; DIP-24258N; -.
DR   IntAct; Q9UK53; 22.
DR   MINT; Q9UK53; -.
DR   STRING; 9606.ENSP00000364929; -.
DR   iPTMnet; Q9UK53; -.
DR   PhosphoSitePlus; Q9UK53; -.
DR   BioMuta; ING1; -.
DR   DMDM; 212276438; -.
DR   EPD; Q9UK53; -.
DR   jPOST; Q9UK53; -.
DR   MassIVE; Q9UK53; -.
DR   PaxDb; Q9UK53; -.
DR   PeptideAtlas; Q9UK53; -.
DR   PRIDE; Q9UK53; -.
DR   ProteomicsDB; 84718; -. [Q9UK53-1]
DR   ProteomicsDB; 84719; -. [Q9UK53-2]
DR   ProteomicsDB; 84720; -. [Q9UK53-3]
DR   ProteomicsDB; 84721; -. [Q9UK53-4]
DR   ProteomicsDB; 84722; -. [Q9UK53-5]
DR   Antibodypedia; 4248; 501 antibodies.
DR   Ensembl; ENST00000333219; ENSP00000328436; ENSG00000153487. [Q9UK53-2]
DR   Ensembl; ENST00000338450; ENSP00000345202; ENSG00000153487. [Q9UK53-4]
DR   Ensembl; ENST00000375775; ENSP00000364930; ENSG00000153487. [Q9UK53-3]
DR   GeneID; 3621; -.
DR   KEGG; hsa:3621; -.
DR   UCSC; uc001vrf.5; human. [Q9UK53-1]
DR   CTD; 3621; -.
DR   DisGeNET; 3621; -.
DR   GeneCards; ING1; -.
DR   HGNC; HGNC:6062; ING1.
DR   HPA; ENSG00000153487; Low tissue specificity.
DR   MalaCards; ING1; -.
DR   MIM; 275355; phenotype.
DR   MIM; 601566; gene.
DR   neXtProt; NX_Q9UK53; -.
DR   OpenTargets; ENSG00000153487; -.
DR   Orphanet; 500481; Squamous cell carcinoma of salivary glands.
DR   Orphanet; 494547; Squamous cell carcinoma of the hypopharynx.
DR   Orphanet; 494550; Squamous cell carcinoma of the larynx.
DR   Orphanet; 502366; Squamous cell carcinoma of the lip.
DR   Orphanet; 500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses.
DR   Orphanet; 502363; Squamous cell carcinoma of the oral cavity.
DR   Orphanet; 500478; Squamous cell carcinoma of the oropharynx.
DR   PharmGKB; PA29872; -.
DR   VEuPathDB; HostDB:ENSG00000153487.12; -.
DR   eggNOG; KOG1973; Eukaryota.
DR   GeneTree; ENSGT00940000155401; -.
DR   HOGENOM; CLU_031900_5_1_1; -.
DR   InParanoid; Q9UK53; -.
DR   OMA; YCVCNQI; -.
DR   OrthoDB; 1434088at2759; -.
DR   PhylomeDB; Q9UK53; -.
DR   TreeFam; TF352014; -.
DR   PathwayCommons; Q9UK53; -.
DR   SIGNOR; Q9UK53; -.
DR   BioGRID-ORCS; 3621; 7 hits in 1010 CRISPR screens.
DR   ChiTaRS; ING1; human.
DR   EvolutionaryTrace; Q9UK53; -.
DR   GeneWiki; ING1; -.
DR   GenomeRNAi; 3621; -.
DR   Pharos; Q9UK53; Tbio.
DR   PRO; PR:Q9UK53; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; Q9UK53; protein.
DR   Bgee; ENSG00000153487; Expressed in decidua and 217 other tissues.
DR   ExpressionAtlas; Q9UK53; baseline and differential.
DR   Genevisible; Q9UK53; HS.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0035064; F:methylated histone binding; IDA:UniProtKB.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; TAS:ProtInc.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0010941; P:regulation of cell death; IEA:InterPro.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR028643; ING1.
DR   InterPro; IPR028651; ING_fam.
DR   InterPro; IPR024610; ING_N_histone-binding.
DR   InterPro; IPR019786; Zinc_finger_PHD-type_CS.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR001965; Znf_PHD.
DR   InterPro; IPR019787; Znf_PHD-finger.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR10333; PTHR10333; 1.
DR   PANTHER; PTHR10333:SF85; PTHR10333:SF85; 1.
DR   Pfam; PF12998; ING; 1.
DR   SMART; SM01408; ING; 1.
DR   SMART; SM00249; PHD; 1.
DR   SUPFAM; SSF57903; SSF57903; 1.
DR   PROSITE; PS01359; ZF_PHD_1; 1.
DR   PROSITE; PS50016; ZF_PHD_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell cycle; Disease variant;
KW   Isopeptide bond; Metal-binding; Nucleus; Reference proteome;
KW   Tumor suppressor; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..422
FT                   /note="Inhibitor of growth protein 1"
FT                   /id="PRO_0000212661"
FT   ZN_FING         353..402
FT                   /note="PHD-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00146"
FT   REGION          405..422
FT                   /note="PBR"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H160"
FT   METAL           356
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000269|PubMed:18533182,
FT                   ECO:0007744|PDB:2QIC"
FT   METAL           358
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000269|PubMed:18533182,
FT                   ECO:0007744|PDB:2QIC"
FT   METAL           369
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000269|PubMed:18533182,
FT                   ECO:0007744|PDB:2QIC"
FT   METAL           374
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000269|PubMed:18533182,
FT                   ECO:0007744|PDB:2QIC"
FT   METAL           380
FT                   /note="Zinc 1; via pros nitrogen"
FT                   /evidence="ECO:0000269|PubMed:18533182,
FT                   ECO:0007744|PDB:2QIC"
FT   METAL           383
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000269|PubMed:18533182,
FT                   ECO:0007744|PDB:2QIC"
FT   METAL           396
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000269|PubMed:18533182,
FT                   ECO:0007744|PDB:2QIC"
FT   METAL           399
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000269|PubMed:18533182,
FT                   ECO:0007744|PDB:2QIC"
FT   SITE            355
FT                   /note="Histone H3K4me3 binding"
FT                   /evidence="ECO:0000269|PubMed:18533182,
FT                   ECO:0007744|PDB:2QIC"
FT   SITE            366
FT                   /note="Histone H3K4me3 binding"
FT                   /evidence="ECO:0000269|PubMed:18533182,
FT                   ECO:0007744|PDB:2QIC"
FT   SITE            370
FT                   /note="Histone H3K4me3 binding"
FT                   /evidence="ECO:0000269|PubMed:18533182,
FT                   ECO:0007744|PDB:2QIC"
FT   SITE            378
FT                   /note="Histone H3K4me3 binding"
FT                   /evidence="ECO:0000269|PubMed:18533182,
FT                   ECO:0007744|PDB:2QIC"
FT   CROSSLNK        278
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         1..212
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10626813,
FT                   ECO:0000303|PubMed:10807544"
FT                   /id="VSP_009129"
FT   VAR_SEQ         1..189
FT                   /note="MSFVECPYHSPAERLVAEADEGGPSAITGMGLCFRCLLFSFSGRSGVEGGRV
FT                   DLNVFGSLGLQPWIGSSRCWGGPCSSALRCGWFSSWPPPSKSAIPIGGGSRGAGRVSRW
FT                   PPPHWLEAWRVSPLPLSPLSPATFGRGFIAVAVIPGLWARGRGCSSDRLPRPAGPARRQ
FT                   FQAASLLTRGWGRAWPWKQ -> MLSPANGEQLHLVNYVEDYLDSIESLPFDLQRNVSL
FT                   MREIDAKYQE (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10626813,
FT                   ECO:0000303|PubMed:10807544, ECO:0000303|PubMed:11481424,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:8944021"
FT                   /id="VSP_009126"
FT   VAR_SEQ         1..189
FT                   /note="MSFVECPYHSPAERLVAEADEGGPSAITGMGLCFRCLLFSFSGRSGVEGGRV
FT                   DLNVFGSLGLQPWIGSSRCWGGPCSSALRCGWFSSWPPPSKSAIPIGGGSRGAGRVSRW
FT                   PPPHWLEAWRVSPLPLSPLSPATFGRGFIAVAVIPGLWARGRGCSSDRLPRPAGPARRQ
FT                   FQAASLLTRGWGRAWPWKQ -> ME (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:10626813,
FT                   ECO:0000303|PubMed:14702039"
FT                   /id="VSP_009127"
FT   VAR_SEQ         1..189
FT                   /note="MSFVECPYHSPAERLVAEADEGGPSAITGMGLCFRCLLFSFSGRSGVEGGRV
FT                   DLNVFGSLGLQPWIGSSRCWGGPCSSALRCGWFSSWPPPSKSAIPIGGGSRGAGRVSRW
FT                   PPPHWLEAWRVSPLPLSPLSPATFGRGFIAVAVIPGLWARGRGCSSDRLPRPAGPARRQ
FT                   FQAASLLTRGWGRAWPWKQ -> MSFVECPYHSPAERLVAEADEGGPSAITE (in
FT                   isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_009128"
FT   VARIANT         125
FT                   /note="L -> R (in dbSNP:rs7338333)"
FT                   /evidence="ECO:0000269|PubMed:10807544,
FT                   ECO:0000269|PubMed:10866301, ECO:0000269|PubMed:8944021"
FT                   /id="VAR_047097"
FT   VARIANT         335
FT                   /note="A -> D (in HNSCC)"
FT                   /evidence="ECO:0000269|PubMed:10866301"
FT                   /id="VAR_017420"
FT   VARIANT         358
FT                   /note="C -> S (in HNSCC)"
FT                   /evidence="ECO:0000269|PubMed:10866301"
FT                   /id="VAR_017421"
FT   VARIANT         359
FT                   /note="N -> S (in HNSCC)"
FT                   /evidence="ECO:0000269|PubMed:10866301"
FT                   /id="VAR_017422"
FT   MUTAGEN         378
FT                   /note="W->A: Unable to stimulate DNA repair after UV
FT                   irradiation or promote DNA-damage-induced apoptosis."
FT                   /evidence="ECO:0000269|PubMed:18533182"
FT   CONFLICT        266
FT                   /note="A -> V (in Ref. 1; AAC00501/AAB60879, 3 and 6)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        272
FT                   /note="A -> V (in Ref. 1; AAC00501/AAB60879, 3 and 6)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        278
FT                   /note="K -> N (in Ref. 1; AAC00501/AAB60879, 3 and 6)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        280
FT                   /note="E -> D (in Ref. 1; AAC00501/AAB60879, 3 and 6)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        282
FT                   /note="A -> V (in Ref. 1; AAC00501/AAB60879, 3 and 6)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        285
FT                   /note="A -> S (in Ref. 1; AAC00501/AAB60879, 3 and 6)"
FT                   /evidence="ECO:0000305"
FT   TURN            356..359
FT                   /evidence="ECO:0007744|PDB:2QIC"
FT   STRAND          364..368
FT                   /evidence="ECO:0007744|PDB:2QIC"
FT   STRAND          378..380
FT                   /evidence="ECO:0007744|PDB:2QIC"
FT   HELIX           382..384
FT                   /evidence="ECO:0007744|PDB:2QIC"
FT   HELIX           397..400
FT                   /evidence="ECO:0007744|PDB:2QIC"
SQ   SEQUENCE   422 AA;  46738 MW;  03D6AEEAA6E39090 CRC64;
     MSFVECPYHS PAERLVAEAD EGGPSAITGM GLCFRCLLFS FSGRSGVEGG RVDLNVFGSL
     GLQPWIGSSR CWGGPCSSAL RCGWFSSWPP PSKSAIPIGG GSRGAGRVSR WPPPHWLEAW
     RVSPLPLSPL SPATFGRGFI AVAVIPGLWA RGRGCSSDRL PRPAGPARRQ FQAASLLTRG
     WGRAWPWKQI LKELDECYER FSRETDGAQK RRMLHCVQRA LIRSQELGDE KIQIVSQMVE
     LVENRTRQVD SHVELFEAQQ ELGDTAGNSG KAGADRPKGE AAAQADKPNS KRSRRQRNNE
     NRENASSNHD HDDGASGTPK EKKAKTSKKK KRSKAKAERE ASPADLPIDP NEPTYCLCNQ
     VSYGEMIGCD NDECPIEWFH FSCVGLNHKP KGKWYCPKCR GENEKTMDKA LEKSKKERAY
     NR
//
